Should hypertensive patients take vitamin d?

Current Hypertension Reports

Volumn 14, Issue 4, 2012, Pages 318-323

  Wuerzner, Gregoire ^a   Burnier, Michel ^a   Waeber, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Hypertension; Renin angiotensin system; Vitamin D; Vitamin receptor

Indexed keywords

25 HYDROXYVITAMIN D; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; CALCIUM; COLECALCIFEROL; DOXERCALCIFEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERGOCALCIFEROL; PARICALCITOL; PLACEBO; VITAMIN D; VITAMIN D RECEPTOR;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD PRESSURE MONITORING; BONE TURNOVER; CHRONIC DISEASE; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; HUMANS; HYPERTENSION; RECEPTORS, CALCITRIOL; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D; VITAMINS;

EID: 84865660953     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0271-x     Document Type: Article

References (35)

1. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42 (6):1206-52. (Pubitemid 37553153)
2. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25(9):1751-62. (Pubitemid 47356612)
3. Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: Summary of NICE guidance. BMJ. 2011;343.
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357 (3):266-81.
5. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86(2):888-94. (Pubitemid 32207511)
6. Pike JW, Meyer MB. The vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin N Am. 2010;39(2): 255-69.
7. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726-76.
8. Kong J, Li YC. Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice. Am J Physiol Regul Integr Comp Physiol. 2003;285(1):R255-61. (Pubitemid 36736524)
9. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-Angiotensin system. J Clin Invest. 2002;110(2):229-38. (Pubitemid 34787360)
10. Zhou C, Lu F, Cao K, et al. Calcium-independent and 1,25 (OH)2D3-dependent regulation of the renin-Angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008;74(2): 170-9. (Pubitemid 351915078)
11. Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007;103(3-5): 521-4. (Pubitemid 46420533)
12. Tiosano D, Schwartz Y, Braver Y, et al. The renin-Angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res. 2011;26(9):2252-60.
13. Dong J, Wong SL, Lau CW et al: Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. European Heart Journal 2012.
14. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;105 (5):649-54. (Pubitemid 17176965)
15. Vaidya A, Sun B, Forman JP et al: The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clinical Endocrinology 2011, 74(6):783-790. This genetic assocition study adds new evidence between the interaction of the Fok1 vitamin D receptor gene polymorphism and the renin angiotensin system.
16. Bukoski RD, DeWan P, McCarron DA. 1,25 (OH)2 vitamin D3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. Am J Hypertens. 1989;2 (7):553-6. (Pubitemid 19184130)
17. Wakasugi M, Noguchi T, Inoue M, et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. 1991;42(2):127-36.
18. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94(10):4023-30.
19. Harris RA, Pedersen-White J, Guo DH, et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens. 2011;24 (5):557-62.
20. Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010;95 (10):4584-91.
21. Kristal-Boneh E, Froom P, Harari G, Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension. 1997;30(5):1289-94. (Pubitemid 27476193)
22. Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: A population-based study in older men and women. J Intern Med. 2007;261(6):558-65. (Pubitemid 46835978)
23. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063-9. (Pubitemid 351664326)
24. Jorde R, Figenschau Y, Emaus N, et al. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010;55(3):792-8.
25. Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: A metaanalysis. J Hypertens. 2011;29(4):636-45.
26. Zhao G, Ford ES, Li C, et al. Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens. 2010;28 (9):1821-8.
27. Margolis KL, Martin LW, Ray RM, et al. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol. 2012;175(1):22-32.
28. Zhao G, Ford ES, Li C, Croft JB: Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: The NHANES linked mortality study. J Hypertens 2012, 30(2):284-289. The retrospective epidemiological study base on the NHANES found that in patients with hypertension low levels of 25(OH)D were inversely associated with all-cause and CVD mortality in the US.
29. Krause R, Buhring M, Hopfenmuller W, et al. Ultraviolet B and blood pressure. Lancet. 1998;352(9129):709-10. (Pubitemid 28398716)
30. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49(9):640-6.
31. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-Term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86(4):1633-7. (Pubitemid 32377290)
32. de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial. Lancet. 2010;376(9752):1543-51.
33. Pittas AG, Chung M, Trikalinos T et al: Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152(5):307-314. This systematic review from the literature studied the relationship between vitamin D status or supplementation on cardiovascular outcomes. It underlines the heterogeneity of observational studies and concludes that the assocation between vitamin D and cardiovascular outcome is uncertain.
34. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: A systematic review and meta-Analysis. J Hypertens. 2009;27(10):1948-54.
35. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-37.